AIA Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
AIA Group's BMY Position: Q1 2026 in Review
AIA Group increased its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, buying an estimated $1.86M and bringing the position to 189,914 shares worth $11.5M. The position accounts for 0.17% of the portfolio, ranked #89.
AIA Group first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- AIA Group held 189,914 shares of Bristol-Myers Squibb worth $11.5M as of Q1 2026.
- AIA Group bought 31,842 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.86M.
- Bristol-Myers Squibb made up 0.17% of AIA Group's portfolio in Q1 2026, its #89 holding.
- AIA Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.